Pharma major Glenmark Pharmaceuticals Limited announced the appointment of Vijayalakshmi Rajaram Iyer as an Additional Director on the company’s Board, with effect from February 10, 2023. According to the company’s exchange filing, “Based on the recommendation of the Nomination and Remuneration Committee, the Board of the Company at its Meeting held today has approved the…
Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, announced it has received the “India Pharma Innovation of the Year” Award, as part of the India Pharma & India Medical Device Awards 2021. The 6th edition of the annual awards is jointly organized by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, The Federation of…
Glenmark Pharmaceuticals Ltd., a research-led, integrated global pharmaceutical company, announced that it has entered into a definitive agreement with Dr. Reddy’s Laboratories Ltd. to divest its brand Momat Rino (for Russia, Kazakhstan and Uzbekistan), Momat Rino Advance (for Russia), Momat A (for Kazakhstan and Uzbekistan), Glenspray and Glenspray Active (for Ukraine), along with rights to…
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the appointment of Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization for a period of five years with effect from 14th August, 2020. Bhattacharjee comes with over 30 years of global experience in leading Generics, Specialty and OTC Pharma, Medical Devices, and…
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the launch of the world’s first hypertension awareness symbol, in collaboration with Association of Physicians of India (API) and Hypertension Society of India (HSI). The symbol is developed in consultation with 50,000 leading doctors in the country, to raise awareness of the growing burden of hypertension…
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu to closely monitor the efficacy and safety of the drug in 1000 patients that are prescribed with the oral antiviral, as part of an open label, multicenter, single arm study. Further, Glenmark has announced…
Hindustan Unilever Limited (HUL), India’s largest fast-moving consumer goods company, announced that it has completed the acquisition of intimate hygiene brand VWash from Glenmark Pharmaceuticals Ltd. This acquisition was announced on March 23, 2020 and was subject to certain closing conditions, which have now been fulfilled, the Company said in their press statement. Launched in 2013…
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the launch of antiviral drug Favipiravir (brand name FabiFlu) for the treatment of mild to moderate COVID-19 patients. Glenmark has received manufacturing and marketing approval from India’s drug regulator, making FabiFlu the first oral Favipiravir-approved medication in India for the treatment of COVID-19, the company said.…
Glenmark Pharmaceuticals, a research-led integrated global pharmaceutical company, announced that it has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval from India’s drug regulator DCGI in late April. Glenmark claims to be the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19…
True North, a private equity firm, has agreed to acquire Glenmark Pharmaceuticals Ltd’s gynaecology business in India and Nepal for Rs 115 crore. The acquisition will be done through True North’s portfolio company, Integrace Pvt. Ltd. All formalities related to acquisition will be completed by March. The acquisition is the second such engagement between True…